Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 1699Glioblastoma 1307Glioma 992Neuroblastoma 408Central Nervous System Neoplasms 384Astrocytoma 383Gliosarcoma 286Oligodendroglioma 237Neoplasms 226Breast Neoplasms 216Meningioma 179Medulloblastoma 172Carcinoma, Non-Small-Cell Lung 149Recurrence 147Neoplasm Metastasis 138Lung Neoplasms 138Ependymoma 127Melanoma 118Sarcoma 116Neurofibromatosis 1 110Meningeal Carcinomatosis 107Lymphoma 94Neuroma, Acoustic 82Diffuse Intrinsic Pontine Glioma 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Lymphoma, Follicular 73Pheochromocytoma 71Paraganglioma 68

Interventions

Gadolinium 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adult Brain Glioblastoma × CNS × Clear all
NCT00660543 2017-05-16

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Completed
14 enrolled 6 charts
CNS

Adult Brain Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡